研究单位：[1]Department of infectious disease,Tongji Hospital,Wuhan,Hubei,China,430030感染科[2]Anhui Provincial Hospital[3]The First Affiliated Hospital of Nanchang University[4]Taihe Hospital, Hubei University of Medicine[5]The First Hospital of Jilin University
End stage liver disease is prone to thrombocytopenia. This study is a multi-center, randomized, prospective, randomized controlled Phase IV Clinical trial to discuss the Efficacy and Safety of Avatrombopag in Patients with End-stage Liver Disease and Thrombocytopenia.
